Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood

Platelets

Volumn 16, Issue 3-4, 2005, Pages 171-179

  Gonzalez Correa J A ^a   Arrebola, M M ^a   Guerrero, A ^a   Munoz Marin J ^a   Ruiz Villafranca, D ^a   Sanchez De La Cuesta F ^a   De La Cruz, J P ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Acetylsalicylic acid; Alpha tocopherol; Nitric oxide; Platelets; Thromboxane; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ALPHA TOCOPHEROL; ARACHIDONIC ACID; COLLAGEN; NITRIC OXIDE; PROSTACYCLIN; PROSTANOID; THROMBOXANE B2;

ADULT; ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; BINDING SITE; COLLAGEN METABOLISM; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IC 50; IN VITRO STUDY; INHIBITION KINETICS; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; CELLS, CULTURED; COLLAGEN; DRUG SYNERGISM; EPOPROSTENOL; HUMANS; INHIBITORY CONCENTRATION 50; LEUKOCYTES; MALE; MIDDLE AGED; NITRIC OXIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDINS; THROMBOXANE B2; VITAMIN E;

EID: 21344443470     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100400016797     Document Type: Article

References (40)

1. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994;1:333-9.
2. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol 1994;74:64-5.
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324(7329):71-86.
4. De la Cruz JP, Sánchez de la Cuesta F. Does the association dipyridamole-aspirin only act by a functional synergism? Gen Pharmacol 1991;22(2):271-4.
5. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143(1-2):1-13.
6. Forbes CD. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study. Thromb Res 1998;92(Suppl. 1):S1-6.
7. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med 1993;328:1444-9.
8. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary disease in men. New Engl J Med 1993;328:1450-6.
9. Mitchinson MJ, Stephens NG, Parsons A, Bligh E, Schofield PM, Brown MJ. Mortality in the CHAOS trial. Lancet 1999;353:381-2.
10. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combi-nations, cancer incidence and disease specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
11. Virtamo J, Rapola JM, Ripalti S, Heirnonen OP, Taylor PR, Albanes K, Huttunen JK. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998;158:668-75.
12. Celestini A, Pulcinelli FM, Pignatelli P, Lenti L, Frati G, Gazzaniga PP, Violi F. Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica 2002;87:420-6.
13. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 1995;62:1381-4S.
14. Cardinal DC, Flowers JR. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharm Methods 1980;3:135-8.
15. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991;349:326-8.
16. Higashi O, Kikuchi Y. Effects of vitamin E on the aggregation and lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med 1974;112:271-8.
17. Calzada C, Bruckdorfer K, Rice Evans C. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 1997;128:97-105.
18. Takamatsu S, Takamatsu M, Satoh K. Effects on health of dietary supplementation with 100 mg δ-α-tocopheryl acetate, daily for 6 years. J Int Med Res 1995;23:342-57.
19. Marcus AJ. Thrombosis and inflammation as multicelular processes: significance of cell-cell interactions. Semin Haematol 1994;31(4):261-9.
20. De Gaetano G, Evangelista V, Rajtar G, Del Maschio A, Cerletti A. Activated polymorphonuclear leucocytes stimulate platelet function. Thromb Res 1990;Suppl XI:25-32.
21. Lopez-Farre A, Caramelo C, Esteban A, Alberola ML, Millas I, Monton M, Casado S. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 1995;91(7):2080-8.
22. De la Cruz JP, Blanco E, Sánchez de la Cuesta F. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 2000;397(1):35-41.
23. De la Cruz JP, Bellido I, Camara S, Martos F, Sanchez de la Cuesta F. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study. Scand J Haematol 1986;36(4):394-7.
24. De la Cruz JP, Camara S, Bellido I, Carrasco T, Sánchez de la Cuesta F. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb Res 1987;46(1):133-40.
25. Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8(5):270-6.
26. Steiner M, Anastasi J, Vitamin E: an inhibitor of the platelet release reaction. J Clin Invest 1976;57:732-7.
27. Ferns GA, Forster LA, Williams JC, Tull SP, Verma PK, Starkey B, Gershlick AH. Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty. Ann Clin Biochem 2000;37(Pt.5):649-54.
28. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000;28(1):141-64.
29. Freedman JE, Farhat JH, Loscalzo J, Keaney JF. α-Tocopherol inhibits aggregation of human platelets by protein kinase C-dependent mechanism. Circulation 1996;94:2434-40.
30. Kroll MH, Heliums JD, Guo Z, Durante W, Razdan D, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 1993;268:3520-4.
31. Freedman JE, Keany JF. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001;131:374-7S.
32. Liu M, Wallmon A, Olson-Morlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potencial mechanisms. Am J Clin Nutr 2003;77:700-6.
33. Vane JR. The mode of action os aspirin-like drugs. Agents Actions 1978;8(4):430-1.
34. Agradi E, Petroni A, Socini A, Galli C. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation. Prostaglandins 1981;22(2):255-66.
35. Sheu JR, Lee CR, Hsiao G, Hung WC, Lee YM, Chen YC, Yen MH. Comparison of the relative activities of α-tocopherol and PMC on platelet aggregation and antioxidative activity. Life Sci 1999;65 (2):197-206.
36. Gryglewski RJ, Szczeklik A. Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis. Mater Med Pol 1978;10(4):338-41.
37. Li D, Saldeen T, Romeo F, Mehta JL. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E. Cardiovasc Pharmacol Ther 2001;6(2):155-61.
38. Keaney JF, Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J 1999;13:965-76.
39. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y. Vitamin E administration improves impairment of endothelium- dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32(6):1672-9.
40. Keaney JF, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of a-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 1996;98(2):386-94.